Preoperative recombinant human erythropoietin in anemic surgical patients

Critical Care

Volumn 8, Issue SUPPL. 2, 2004, Pages

  Monk, Terri G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Allogeneic blood transfusions; Anemia; Recombinant human erythropoietin; Surgical patients

Indexed keywords

IRON; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLOOD AUTOTRANSFUSION; CANCER SURGERY; CLINICAL TRIAL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; ELECTIVE SURGERY; ERYTHROPOIESIS; HEART SURGERY; HUMAN; ORTHOPEDIC SURGERY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SURGICAL PATIENT; TREATMENT OUTCOME;

ANEMIA; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR DISEASES; ERYTHROPOIETIN, RECOMBINANT; HUMANS; MONITORING, INTRAOPERATIVE; NEOPLASMS; PREMEDICATION; TREATMENT OUTCOME;

EID: 4344623283     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc2824     Document Type: Review

References (53)

1. Keating EM, Ritter MA: Transfusion options in total joint arthroplasty. J Arthoplasty 2002, 17:125-128.
2. Dunne JR, Malone D, Tracy JK, Gannon C, Napolitano LM: Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 2002, 102:237-244.
3. Carson JL, Duff RM, Berlin JA, Spence RK, Trout R, Noveck H, Strom BL: Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996, 348:1055-1060.
4. Baraldi-Junkins CA, Beck AC, Rothstein G: Hematopoiesis and cytokines. Relevance to cancer and aging. Hematol Oncol Clin North Am 2000,14:45-61.
5. Adunsky A, Lichtenstein A, Mizrahi E, Arad M, Heim M: Blood transfusion requirements in elderly hip fracture patients. Arch Gerontol Geriatr 2003, 36:75-81.
6. Denison U, Baumann J, Peters-Engl C, Samonigg H, Krippl P, Lang A, Obermair A, Wagner H, Sevelda P: Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat 2003, 79:347-353.
7. Keating EM, Meding JB: Perioperative blood management practices in elective orthopaedic surgery. J Am Acad Orthop Surg 2002,10:393-400.
8. Lee SJ, Liljas B, Churchill WH, Popovsky MA, Stowell CP, Cannon ME, Johannesson M: Perceptions and preferences of autologous blood donors. Transfusion 1998, 38:757-763.
9. Nappi J: Anemia in patients with coronary artery disease. Am J Health Syst Pharm 2003, Suppl 3:S4-S8.
10. Benoist S, Panis Y, Pannegeon V, Alves A, Valleur P: Predictive factors for perioperative blood transfusions in rectal resection for cancer: a multivariate, analysis of a group of 212 patients. Surgery 2001, 129:433-439.
11. Chang H, Hall GA, Geerts WH, Greenwood C, McLeod IRS, Sher GD: Allogeneic red blood cell transfusion is an independent risk factor for the development of postoperative bacterial infection. Vox Sang 2000, 78:13-18.
12. Amato AC, Pescatori M: Effect of perioperative blood transfusions on recurrence of colorectal cancer: meta-analysis stratified on risk factors. Dis Colon Rectum 1998, 41:570-585.
13. Brand A: Immunological aspects of blood transfusions. Blood Rev 2000,14:130-144.
14. Vamvakas EC, Carven JH: Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 1998,122:145-151.
15. McCullough J: Progress toward a pathogen-free blood supply. Clin Infect Dis 2003, 37:88-95.
16. Hutchinson AB, Fergusson D, Graham ID, Laupacis A, Herrin J, Hillyer CD: Utilization of technologies to reduce allogeneic blood transfusion in the United States. Transfus Med 2001, 11: 79-85.
17. Hogue CW Jr, Goodnough LT, Monk TG: Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion 1998, 38:924-931.
18. Dunne JR, Gannon CJ, Osborn TM, Taylor MD, Malone DL, Napolitano LM: Preoperative anemia in colon cancer: assessment of risk factors. Am Surg 2002, 68:582-587.
19. Arnoux R, Corman J, Peloquin A, Smeesters C, St Louis G: Adverse effect of blood transfusions on patient survival after resection of rectal cancer. Can J Surg 1988, 31:121-126.
20. Procrit® epoetin alfa [prescribing information]. Bridgewater, NJ: Ortho Biotech Products, LP; 2002.
21. Goodnough LT, Monk TG, Andriole GL: Erythropoietin therapy. N Engl J Med 1997, 336:933-938.
22. Monk TG, Goodnough LT, Brecher ME, Colberg JW, Andriole GL, Catalona WJ: A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology 1999, 91:24-33.
23. Brecher ME, Goodnough LT, Monk T: Where does preoperative erythropoietin therapy count? A mathematical perspective. Transfusion 1999, 39:392-395.
24. Avall A, Hyllner M, Bengtson JP, Carlsson L, Bengtsson A: Recombinant human erythropoietin in preoperative autologous blood donation did not influence the haemoglobin recovery after surgery. Acta Anaesthesiol Scand 2003, 47:687-692.
25. Goldberg MA: Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusions: results of randomized clinical trials. Semin Hematol 1997, 34:41-47.
26. Faris PM, Ritter MA, Abels RI: The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J Bone Joint Surg Am 1996, 78:62-72.
27. Goldberg MA, McCutchen JW, Jove M, Di Cesare P, Friedman RJ, Poss R, Guilfoyle M, Frei D, Young D: A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 1996, 25:544-552.
28. Lofthouse RA, Boitano MA, Davis JR, Jinnah RH: Preoperative administration of epoetin alfa to reduce transfusion requirements in elderly patients having primary total hip or knee reconstruction. J South Orthop Assoc 2000, 9:175-181.
29. Rauh MA, Bayers-Thering M, LaButti IRS, Krackow KA: Preoperative administration of epoetin alfa to total joint arthroplasty patients. Orthopedics 2002, 25:317-320.
30. de Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC: Baseline hemoglobin as a predictor of risk of transfusion and response to epoetin alfa in orthopedic surgery patients. Am J Orthop 1996, 25:533-542.
31. Fearon JA, Weinthal J: The use of recombinant erythropoietin in the reduction of blood transfusion rates in craniosynostosis repair in infants and children. Plast Reconstr Surg 2002, 109: 2190-2196.
32. Laupacis A, Fergusson D: Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Transfus Med 1998, 8:309-317.
33. Yazicioglu L, Eryilmaz S, Sirlak M, Inan MB, Aral A, Tasoz R, Eren NT, Kaya B, Akalin H: Recombinant human erythropoietin administration in cardiac surgery. J Thoac Cardiovasc Surg 2001, 122:741-745.
34. Qvist N, Boesby S, Wolff B, Hansen CP: Recombinant human erythropoietin and hemoglobin concentration at operation and during the postoperative period: reduced need for blood transfusions in patients undergoing colorectal surgery: prospective double-blind placebo-controlled study. World J Surg 1999, 23:30-35.
35. Kosmadakis N, Messaris E, Maris A, Katsaragakis S, Leandros E, Konstadoulakis MM, Androulakis G: Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: prospective randomized double-blind study. Ann Surg 2003, 237:417-421.
36. Levine EA, Laborde C, Hambrick E, McKnight CA, Vijayakumar S: Influence of erythropoietin on transfusion requirements in patients receiving preoperative chemoradiotherapy for rectal cancer. Dis Colon Rectum 1999, 42:1065-1069.
37. Kettelhack C, Hones C, Messinger D, Schlag PM: Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma. Br J Surg 1998, 85:63-67.
38. Rosenblum N, Levine MA, Handler T, Lepor H: The role of preoperative epoetin alfa in men undergoing radical retropubic prostatectomy. J Urol 2000, 163:829-833.
39. Scott SN, Boeve TJ, McCulloch TM, Fitzpatrick KA, Karnell LH: The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study. Laryngoscope 2002, 112:1221-1229.
40. Sesti F, Ticconi C, Bonifacio S, Piccione E: Preoperative administration of recombinant human erythropoietin in patients undergoing gynecologic surgery. Gynecol Obstet Invest 2002, 54:1-5.
41. Mercuriali F, Zanella A, Barosi G, Inghilleri G, Biffi E, Vinci A, Colotti MT: Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993, 33:55-60.
42. Mercuriali F, Inghilleri G, Biffi E, Colotti MT, Vinci A, Oriani G: Epoetin alfa in low hematocrit patients to facilitate autologous blood donation in total hip replacement: a randomized, double-blind, placebo-controlled, dose-ranging study. Acta Haematol 1998,100:69-76.
43. Goodnough LT, Price TH, Rudnick S, Soegiarso RW: Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy. Transfusion 1992, 32:441-445.
44. Goodnough LT, Price TH, Friedman KD, Johnston M, Ciavarella D, Khan N, Sacher R, Vogler WR, Wissel M, Abels RI: A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. Transfusion 1994, 34:66-71.
45. Braga M, Gianotti L, Vignali A, Gentilini O, Servida P, Bordignon C, Di Carlo V: Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before surgery in anaemic patients with cancer of the gastrointestinal tract. Br J Surg 1995, 82:1637-1640.
46. Hyllner M, Avall A, Swolin B, Bengtson J-P, Bengtsson A: Autologous blood transfusion in radical hysterectomy with and without erythropoietin therapy. Obstet Gynecol 2002, 99:757-762.
47. Lee J-H, Lee SH, Oh JH: Minimal effective dosage of recombinant human erythropoietin in spinal surgery. Clin Orthop 2003, 413:71-76.
48. Cogliano J, Kisner D: Bloodless medicine and surgery in the OR and beyond. AORN J 2002, 76:830, 832-837, 839, 841.
49. Beholz S, Liu J, Thoelke R, Spiess C, Konertz W: Use of desmopressin and erythropoietin in an anaemic Jehovah's Witness patient with severely impaired coagulation capacity undergoing stentless aortic valve replacement. Perfusion 2001, 16: 485-489.
50. Sarac TP, Clifford C, Waters J, Clair DG, Ouriel K: Preoperative erythropoietin and blood conservation management for thoracoabdominal aneurysm repair in a Jehovah's Witness. J Vasc Surg 2003, 37:453-455.
51. Murphy DP, O'Donnell T, McDonnell J, McElwain JP: Treatment of anaemia in the polytrauma Jehovah's Witness. Ir Med J 2003, 96:8-10.
52. Podesta A, Parodi E, Dottori V, Crivellari R, Passerone GC: Epoetin alpha in elective coronary and valve surgery in Jehovah's Witnesses patients. Experience in 45 patients. Minerva Cardioangiol 2002, 50:125-131.
53. Cothren C, Moore EE, Offner PJ, Haenel JB, Johnson JL: Blood substitute and erythropoietin therapy in a severely injured Jehovah's witness. N Engl J Med 2002, 346:1097-1098.